by Vandana Singh | Mar 5, 2026 | General
An official from the U.S. Food and Drug Administration (FDA) defended the agency’s request for a new placebo-controlled study for uniQure N.V.’s (NASDAQ:QURE) experimental gene therapy for Huntington’s disease. The FDA official noted that the...
by Erica Kollmann | Mar 5, 2026 | General
Dave Inc. (NASDAQ:DAVE) reported a strong fourth-quarter, with its AI-driven underwriting platform CashAI v5.5 powering a 50% year-over-year increase in ExtraCash originations and improving the 28-day past due rate to just 1.89%. DAVE stock is moving. See the chart...
by Kaustubh Bagalkote | Mar 5, 2026 | General
Shares of Adobe Inc (NASDAQ:ADBE) climbed over 3% Thursday as traders positioned ahead of a key earnings catalyst next week. The stock has had a brutal 2026 so far. ADBE is down approximately 16% year-to-date. AI Competition Has Weighed On The Stock The year-to-date...
by Avi Kapoor | Mar 5, 2026 | General
Bath & Body Works, Inc.(NYSE:BBWI) on Wednesday posted upbeat sales for the fourth quarter. The company reported fourth-quarter adjusted earnings per share of $2.05. Quarterly sales of $2.724 billion (down 2% year over year) outpaced the Street view of $1.336...
by Chandrima Sanyal | Mar 5, 2026 | General
The AI trade is entering a new phase where rising expectations alone can’t drive investor enthusiasm. Broadcom Inc. (NASDAQ:AVGO) saw a 5.3% gain Thursday morning after reporting strong quarterly results and rising AI hardware revenue, with $8.4 billion in the latest...
Recent Comments